Literature DB >> 15158005

Telomerase induction in astrocytes of Sprague-Dawley rat after ischemic brain injury.

Sunkyung Baek1, Youngmin Bu, HwaSu Kim, Hocheol Kim.   

Abstract

Telomerase, a reverse transcriptase, consists of an RNA template and protein polymerase. This ribonucleoprotein protects the linearized chromosomal end region and elongates the telomere during chromosomal replication. Telomerase is not expressed in adult somatic cells but it shows high activity in most cells during embryonic development. We report, by RT-PCR and immunohistochemical results, that the induction of telomerase protein catalytic subunit (TERT) in transient middle cerebral artery occlusion induced brain injury. TERT mRNA emerged 24 h after ischemia. We examined which brain cell expressed TERT in the penumbra region of injured brain. The expression of TERT began from 24 h and remained until 5 days after ischemia. We identified that TERT was co-localized with the astrocyte marker, GFAP, at 3 days after ischemia. This is strong evidence that TERT is induced in astrocytes when the brain is damaged by ischemia, and that this enzyme may play an important role in ischemic brain injury.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15158005     DOI: 10.1016/j.neulet.2004.03.059

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  11 in total

Review 1.  DNA damage responses in neural cells: Focus on the telomere.

Authors:  P Zhang; C Dilley; M P Mattson
Journal:  Neuroscience       Date:  2007-01-04       Impact factor: 3.590

2.  Telomere biology in cardiovascular disease - role of insulin sensitivity in diabetic hearts.

Authors:  Naoki Makino; Makoto Sasaki; Toyoki Maeda; Kosi Mimori
Journal:  Exp Clin Cardiol       Date:  2010

3.  Deficiency of telomerase activity aggravates the blood-brain barrier disruption and neuroinflammatory responses in a model of experimental stroke.

Authors:  Bei Zhang; Lei Chen; Karin R Swartz; Dennis Bruemmer; Sung Yong Eum; Wen Huang; Melissa Seelbach; Yean Jung Choi; Bernhard Hennig; Michal Toborek
Journal:  J Neurosci Res       Date:  2010-10       Impact factor: 4.164

4.  Greater endogenous estrogen exposure is associated with longer telomeres in postmenopausal women at risk for cognitive decline.

Authors:  Jue Lin; Candyce H Kroenke; Elissa Epel; Heather A Kenna; Owen M Wolkowitz; Elizabeth Blackburn; Natalie L Rasgon
Journal:  Brain Res       Date:  2010-10-18       Impact factor: 3.252

5.  Resting leukocyte telomerase activity is elevated in major depression and predicts treatment response.

Authors:  O M Wolkowitz; S H Mellon; E S Epel; J Lin; V I Reus; R Rosser; H Burke; M Compagnone; J C Nelson; F S Dhabhar; E H Blackburn
Journal:  Mol Psychiatry       Date:  2011-01-18       Impact factor: 15.992

6.  Telomere Attrition in Induced Pluripotent Stem Cell-Derived Neurons From ALS/FTD-Related C9ORF72 Repeat Expansion Carriers.

Authors:  Hayley Robinson; Sk Imran Ali; Martha Elena Diaz-Hernandez; Rodrigo Lopez-Gonzalez
Journal:  Front Cell Dev Biol       Date:  2022-06-13

7.  Adverse childhood experiences and leukocyte telomere maintenance in depressed and healthy adults.

Authors:  Stephen H Chen; Elissa S Epel; Synthia H Mellon; Jue Lin; Victor I Reus; Rebecca Rosser; Eve Kupferman; Heather Burke; Laura Mahan; Elizabeth H Blackburn; Owen M Wolkowitz
Journal:  J Affect Disord       Date:  2014-08-05       Impact factor: 4.839

8.  Comparisons of telomere lengths in peripheral blood and cerebellum in Alzheimer's disease.

Authors:  J Nicholas Lukens; Vivianna Van Deerlin; Christopher M Clark; Sharon X Xie; F Brad Johnson
Journal:  Alzheimers Dement       Date:  2009-11       Impact factor: 21.566

Review 9.  Telomerase in Brain: The New Kid on the Block and Its Role in Neurodegenerative Diseases.

Authors:  Gabriele Saretzki; Tengfei Wan
Journal:  Biomedicines       Date:  2021-04-29

10.  Novel telomerase-increasing compound in mouse brain delays the onset of amyotrophic lateral sclerosis.

Authors:  Erez Eitan; Ailon Tichon; Aviv Gazit; Daniel Gitler; Shimon Slavin; Esther Priel
Journal:  EMBO Mol Med       Date:  2012-02-20       Impact factor: 12.137

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.